Dainippon To Acquire Sepracor For $2.6B
Dainippon Sumitomo Pharma Co. Ltd. said Thursday that it would acquire Sepracor Inc. for $2.6 billion, in a move that will boost the Japanese company's U.S. presence and expand its pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article